Iter Investments

"Over 131 million people in the United States, that’s over 66% of the population, are currently prescribed to a prescription medication," said Courtney Barnes, a partner at a New York-based cannabis and psychedelics law firm Feldman Legal Advisors. "Of those prescription medications available...

Apex Labs Ltd., an Iter Investment’s portfolio biopharma company developing psilocybin therapeutics, has been granted approval by Health Canada to begin its large take-home psilocybin clinical trial.  The randomized, double-blind, placebo-controlled Phase 2b study will evaluate the...

Nucleus is launching an crowdfunding campaign with the goal of expanding people’s relation with the psychedelics industry. The venture studio subsidiary to VC firm Iter Investments is aiming to impulse psychedelic-assisted therapy forward in the midst of the...

Beckley Retreats has completed the first close of a seed round, earning a $1.5 million investment. The initiative was led by Iter Investments and joined by the Joe and Sandy Samberg Foundation and 5D World. The funds will help Beckley increase the number of its science-...

Psychedelics VC fund Iter Investments has recently closed its last round of Fund I with over $20 million committed, a successful outcome considering the targeted raise in their first fund launch in April 2021, and an indication of investor interest in the psychedelics market. Iter’s team...

Dustin Robinson is a leading legal expert in the cannabis and psychedelic space and a founding partner of Mr. Cannabis Law, a law firm focused on the cannabis and psychedelic industries.  Robinson will be speaking at the Benzinga Psychedelics Capital Conference in...

Florida's medical cannabis market is a top performer, with a booming industry backed by a sizable patient count. Solid sales and patient counts serve as an appeal to would-be investors and entrepreneurs. Data from the 2021 Marijuana Business Factbook projects Florida generating between $775...